Loading clinical trials...
Loading clinical trials...
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Astellas Pharma Inc
NCT04950712 · Herpes Genitalis
NCT02837575 · Herpes Genitalis
NCT02852876 · Herpes Genitalis, Herpes Zoster
NCT00405821 · HIV Infections, Herpes Genitalis
NCT00076232 · HIV Infections, HIV Seronegativity, and more
Birmingham, Alabama
Phoenix, Arizona
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions